Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 6/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | SHBG | P04278 | 3/20 | 0.69 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | G6PD | P11413 | 2/20 | 0.64 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6058843 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL5530806 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL497468 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL1418742 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL1418992 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL497467 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL5489583 | 1.00 | GPBAR1 (0.69) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL1418725 | 0.85 | GPBAR1 (0.68) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL6441377 | 0.85 | GPBAR1 (0.68) | GPBAR1LMNASHBGSERPINA6CYP3A4 | |
| SCHEMBL4944130 | 0.85 | GPBAR1 (0.68) | GPBAR1LMNASHBGSERPINA6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050256095-A1 | Asthma and colitis treatment methods | BIOVIE INC. | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256095-A1 | Asthma and colitis treatment methods | HSD3B1, HSD17B1, HSD11B1 | GPBAR1 138/4885LMNA 4427/4885SHBG 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.